News and Events

View upcoming Enterprise Innovation information sessions, seminars, symposia and events on our monthly calendar.

Cornell Engineering and Weill Cornell Medicine Pilot M.D.-M.Eng. Degree

May 10, 2023

As part of a new cross-college initiative designed to accelerate engineering innovations in medicine, Cornell Engineering is piloting an M.D.-M.Eng. program that allows medical students at Weill Cornell Medicine to earn a one-year professional Master of Engineering degree while they are in medical school.

App-Based Communication Tool Receives NIH Funding

May 8, 2023

VoiceLove LLC, a startup founded by two Weill Cornell Medicine physicians, was awarded a $3 million fast-track Phase 1-Phase 2 grant by the National Institute on Aging of the National Institutes of Health to further develop and test in clinical trial a prototype app designed to help critically ill patients in hospital intensive care units connect with their families.

Biotechnology Company Founded on Weill Cornell Technology Announced $90 Million Series A Financing to Advance Radioantibody Treatment for Cancer

May 8, 2023

Convergent Therapeutics Inc., a clinical-stage biotechnology company co-founded by Dr. Neil Bander, the Bernard and Josephine Chaus Professor of Urologic Oncology, announced May 3 the completion of a $90 million Series A financing. Convergent focuses on developing next-generation radiopharmaceuticals for the treatment of cancer. The financing will support its development of a pipeline of novel radioantibodies, including its lead program with CONV01-α, for the treatment of advanced prostate cancer.

Robert Langer ’70 Receives Engineering’s Highest Alumni Honor

April 21, 2023

He is the most cited engineer in history. He holds more than 1,400 patents. His pioneering work in biotechnology, drug delivery and tissue engineering has made him one of the most prolific inventors in medicine, and he has co-founded more than 40 companies, including Moderna. For this and many other achievements, Robert Langer ’70 received the Cornell Engineering Distinguished Alumni Award during a celebration hosted Apr. 19 in the Duffield Hall Atrium at Cornell University.

Student Teams Tackle Pressing Health Concerns During Health Hackathon

March 30, 2023

Asthma is personal for Tyler Bershad.

“Like 26 million Americans, I have asthma,” said Bershad, an MBA candidate in business administration at Cornell Tech, during the 2023 Health Hackathon in February. “Asthma is the most prevalent chronic respiratory disease in humans and, unfortunately, those who are most vulnerable are children.”

Startup Symposium & InvestConnect Conference Showcases Weill Cornell Medicine Newcos and Spinouts

March 6, 2023

Dr. Behzad Aghazadeh’s professional ambition carried him to different continents, scientific disciplines and career focuses. But the one constant for the Weill Cornell Medicine alumnus has been a commitment to entrepreneurship.

Radiation Oncologist Partners with Enterprise Innovation to Improve Women's Health Technology

February 17, 2023

In recognition of Cervical Health Awareness Month, Enterprise Innovation spoke with radiation oncologist Dr. Onyinye Balogun about her efforts to improve women's health technology.  Dr. Balogun shared how an encounter with a cervical cancer patient inspired her to become an entrepreneur. 

Neuroscientist Highlights Role of Enterprise Innovation in Advancing Translational Research

February 17, 2023

Enterprise Innovation interviewed rising innovator Dr. Anna Orr. In this conversation, Dr. Orr shares the translational research in neuroscience that is being conducted in her lab as well as how early-career faculty can leverage resources offered by the Weill Cornell Medicine innovation ecosystem to advance their discoveries.

On-Demand Male Contraceptive Shows Promise in Preclinical Study

February 14, 2023

Video of sAC Inhibitor Blocks Sperm Motility

This video shows the motility of human sperm in the absence (left, vehicle control) or presence (right, sAC inhibitor) of the experimental male contraceptive drug candidate. Credit: Dr. Melanie Balbach

Accelerating BioVenture Innovation Advances Another Cohort of Budding Entrepreneurs

December 16, 2022

BioVenture eLab’s intense 15-week Accelerating BioVenture Innovation (ABI) course culminated in an energizing pitch competition on Dec. 6 at Griffis Faculty Club. 

Read the latest news about Enterprise Innovation and Weill Cornell Medicine.

Weill Cornell Medicine Enterprise Innovation 1155 York Ave. New York, NY 10065 Phone: (646) 962-7045